Safety of Long-Acting β-Agonists: Are New Data Really Required? (vol 136, pg 604, 2009)

被引：0
|
作者：
Sears
机构：
来源：
CHEST | 2009年 / 136卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1708 / 1708
页数：1
相关论文
共 50 条
  • [41] Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma
    Xia, Ying
    Kelton, Christina M. L.
    Xue, Liang
    Guo, Jeff J.
    Bian, Boyang
    Wigle, Patricia R.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2013, 4 (06) : 254 - 263
  • [42] An update on the safety of long-acting β-agonists in asthma patients using inhaled corticosteroids
    Salpeter, Shelley R.
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (03) : 407 - 419
  • [43] Update on the safety of long-acting β-agonists in combination with inhaled corticosteroids for the treatment of asthma
    Nelson, Harold S.
    Carr, Warner
    Nathan, Robert
    Portnoy, Jay M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 102 (01) : 11 - 15
  • [44] EVALUATING SAFETY OUTCOMES OF LONG-ACTING BETA AGONISTS (LABAS) IN PATIENTS WITH ASTHMA
    Bian, B.
    Guo, J. J.
    Kelton, C. M.
    Wigle, P.
    VALUE IN HEALTH, 2010, 13 (07) : A561 - A561
  • [45] Safety Profile of long-acting beta 2-Agonists in Patients with Asthma
    Rukavina, Marion
    PNEUMOLOGIE, 2018, 72 (11): : 749 - 749
  • [46] 2 NEW DOPAMINE AGONISTS THAT ARE LONG-ACTING INVIVO BUT SHORT-ACTING INVITRO
    GROSSMAN, A
    YEO, T
    DELITALA, G
    HATHWAY, NR
    BESSER, GM
    CLINICAL ENDOCRINOLOGY, 1980, 13 (06) : 595 - 599
  • [47] Combined analysis of asthma safety trials of long-acting β2-agonists
    Teper, Alejandro
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (01): : E84 - E86
  • [48] Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists
    Busse, William W.
    Bateman, Eric D.
    Caplan, Arthur L.
    Kelly, H. William
    O'Byrne, Paul M.
    Rabe, Klaus F.
    Chinchilli, Vernon M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2497 - 2505
  • [49] Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed
    Jacobson, Glenn A.
    Raidal, Sharanne
    Hostrup, Morten
    Calzetta, Luigino
    Wood-Baker, Richard
    Farber, Mark O.
    Page, Clive P.
    Walters, E. Haydn
    DRUG SAFETY, 2018, 41 (05) : 441 - 449
  • [50] Long-acting β2-agonists:: the new symptom controllers for asthma
    Jenkins, CR
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (05) : 255 - 258
12345